Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic ma…
Biotechnology
US, Tarrytown [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared Regeneron Pharmaceuticals, Inc. (REGN) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology Average | - - | - - | - - | 9,080.61 | 346.49 | -91.38 | -660.42 | -43.16 | 0.00 | 12.5092 | -1.05 | -0.1684 | -21.9299 | -0.09 | -0.10 | 7.2304 | - - | ||
| Maximum | - - | - - | - - | 115,983.00 | 7,384.00 | 1,099.00 | 12,431.00 | 1,058.00 | 0.02 | 701.8537 | 4.26 | 3.0051 | 85.3485 | 0.15 | 8.35 | 61.5621 | - - | ||
| Minimum | - - | - - | - - | 0.00 | 0.00 | -6,783.00 | -56,335.00 | -2,077.00 | 0.00 | -164.8536 | -57.22 | -16.7400 | -1,444.7800 | -1.56 | -12.64 | 0.0007 | - - | ||
| Intellia Therapeutics, Inc. NTLA | 13.80 | 0.68 5.18% | 3,520 vs. 2,168 | 1,405.00 | 28.00 | -107.00 | -123.00 | -1,765.00 | -1.1200 | -6.0491 | 0.0000 | 0.9132 | -3.7130 | -0.1037 | -0.0853 | 8.4537 | 101.00 | ||
| United Therapeutics Corporation UTHR | 367.36 | 3.03 0.83% | 201 vs. 363 | 16,400.00 | 677.00 | 306.00 | 338.00 | 6,333.00 | 6.5200 | 8.7477 | 0.0000 | 0.8924 | 0.4524 | 0.0574 | 0.0472 | 3.5035 | 44.00 | ||
| CRISPR Therapeutics AG CRSP | 46.29 | -0.97 -2.05% | 2,088 vs. 1,262 | 3,951.00 | 0.00 | -116.00 | 109.00 | -1,116.00 | -1.4300 | -11.9580 | 0.0000 | -101.7758 | -231.3313 | -0.0559 | -0.0478 | 17.7168 | 85.00 | ||
| Incyte Corporation INCY | 70.39 | -0.66 -0.93% | 2,109 vs. 2,066 | 13,560.00 | 880.00 | 169.00 | 209.00 | 329.00 | 0.7600 | 18.7480 | 0.0000 | 0.9308 | 0.1925 | 0.0314 | 0.0238 | 3.2913 | 192.00 | ||
| Alnylam Pharmaceuticals, Inc. ALNY | 246.80 | -1.99 -0.80% | 676 vs. 859 | 31,832.00 | 494.00 | -65.00 | -94.00 | -7,075.00 | -0.5200 | -73.3326 | 0.0000 | 0.8665 | -0.1334 | 0.3007 | -0.0172 | 2.8593 | 128.00 | ||
| ImmunoGen, Inc. IMGN | 31.23 | 0.01 0.02% | 19,311 vs. 8,287 | 8,725.00 | 113.00 | 30.00 | 1.00 | -1,708.00 | 0.1000 | 37.1085 | 0.0000 | 0.9810 | 0.2711 | 0.0548 | 0.0374 | 5.4673 | 279.00 | ||
| Apellis Pharmaceuticals, Inc. APLS | 27.75 | 0.26 0.95% | 1,488 vs. 2,868 | 3,451.00 | 172.00 | -66.00 | -133.00 | -2,903.00 | -0.5400 | -27.6326 | 0.0000 | 0.8802 | -0.3855 | -0.2491 | -0.0798 | 2.7985 | 124.00 | ||
| Madrigal Pharmaceuticals, Inc. MDGL | 329.24 | 12.15 3.83% | 421 vs. 376 | 7,180.00 | 0.00 | -147.00 | -149.00 | -1,483.00 | -7.3800 | -8.6674 | 0.0000 | 0.0000 | 0.0000 | -0.1734 | -0.1363 | 9.2623 | 21.00 | ||
| Regeneron Pharmaceuticals, Inc. REGN | 744.50 | 1.15 0.15% | 971 vs. 693 | 80,459.00 | 3,145.00 | 722.00 | 1,350.00 | 27,982.00 | 6.7000 | 36.1813 | 0.0000 | 0.8258 | 0.2296 | 0.0267 | 0.0210 | 4.3960 | 108.00 | ||
| Prometheus Biosciences, Inc. RXDX | 199.92 | 0.18 0.09% | 1,787 vs. 1,217 | 9,558.00 | 1.00 | -40.00 | -40.00 | -371.00 | -0.8600 | -31.1524 | 0.0000 | 1.0000 | -36.9919 | -0.0586 | -0.0539 | 36.9012 | 47.00 | ||
| Arrowhead Pharmaceuticals, Inc. ARWR | 18.28 | -0.43 -2.30% | 743 vs. 1,061 | 2,272.00 | 0.00 | -125.00 | -126.00 | -1,284.00 | -1.0200 | -6.9465 | 0.0000 | 0.0000 | 0.0000 | -0.2590 | -0.1312 | 8.0263 | 124.00 | ||
| Krystal Biotech, Inc. KRYS | 182.29 | 4.19 2.35% | 185 vs. 225 | 5,242.00 | 45.00 | 0.00 | 14.00 | -268.00 | 0.0300 | 1336.3467 | 0.0000 | 0.9465 | 0.0206 | 0.0012 | 0.0011 | 12.2870 | 28.00 | ||
| Reata Pharmaceuticals, Inc. RETA | 172.36 | 0.04 0.02% | 1,909 vs. 954 | 6,566.00 | 22.00 | 192.00 | -70.00 | -1,490.00 | 5.1200 | 5.4820 | 0.0000 | 0.9628 | 8.4849 | 2.2110 | 0.3840 | 2.8209 | 38.00 | ||
| Novo Nordisk A/S NVO | 102.63 | -2.64 -2.51% | 5,655 vs. 4,604 | 444,129.00 | 65,349.00 | 25,407.00 | 5,305.00 | 99,050.00 | 5.7000 | 38.8598 | 0.0072 | 0.8483 | 0.3888 | 0.2569 | 0.0850 | 0.4372 | 4,327.00 | ||
| BioMarin Pharmaceutical Inc. BMRN | 63.45 | 0.89 1.42% | 1,230 vs. 1,774 | 12,092.00 | 648.00 | 88.00 | 12.00 | -532.00 | 0.4700 | 46.3847 | 0.0000 | 0.7850 | 0.1366 | 0.0175 | 0.0129 | 1.5477 | 190.00 | ||
| Ultragenyx Pharmaceutical Inc. RARE | 46.02 | -0.38 -0.82% | 509 vs. 723 | 4,249.00 | 108.00 | -170.00 | -203.00 | -3,558.00 | -2.0300 | -5.7986 | 0.0000 | 0.7576 | -1.5683 | -1.2169 | -0.1306 | 2.1127 | 92.00 | ||
| Sarepta Therapeutics, Inc. SRPT | 110.50 | -0.36 -0.32% | 909 vs. 864 | 10,554.00 | 413.00 | 36.00 | -284.00 | -4,410.00 | 0.3800 | 83.5325 | 0.0000 | 0.8777 | 0.0874 | 0.0376 | 0.0112 | 2.9737 | 95.00 | ||
| PTC Therapeutics, Inc. PTCT | 42.89 | 0.93 2.22% | 581 vs. 714 | 3,307.00 | 210.00 | -91.00 | 6.00 | -3,375.00 | -1.2000 | -5.9705 | 0.0000 | 0.6846 | -0.4358 | 0.1024 | -0.0512 | 1.8854 | 77.00 | ||
| Ionis Pharmaceuticals, Inc. IONS | 33.94 | -1.46 -4.12% | 1,836 vs. 1,635 | 5,359.00 | 119.00 | -142.00 | -155.00 | -1,938.00 | -0.9800 | -11.1954 | 0.0000 | 0.9347 | -1.1950 | -0.4816 | -0.0517 | 6.7492 | 157.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.